According to the research report, the global protontherapy market size is expected to touch USD 1.9 Billion by 2030, from USD 452.33 Billion in 2021, growing with a significant CAGR of 17.29% from 2022 to 2030.
The proton therapy market report offers a
comprehensive study of the current state expected at the major drivers, market
strategies, and key vendors’ growth. The report presents energetic visions to
conclude and study the market size, market hopes, and competitive surroundings.
The research also focuses on the important achievements of the market, research
& development, and regional growth of the leading competitors operating in
the market. The current trends of the global proton therapy market in
conjunction with the geographical landscape of this vertical have also been
included in this report.
The report offers intricate dynamics about
different aspects of the global proton therapy market, which aids companies operating
in the market in making strategic development decisions. The study also
elaborates on significant changes that are highly anticipated to configure
growth of the global proton therapy market during the forecast period. It also
includes a key indicator assessment that highlights growth prospects of this
market and estimates statistics related to growth of the market in terms of
value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/2337
Report Coverage | Details |
Market Size in 2022 | USD 530.53 million |
Market Size by 2030 | USD 1.9 Billion |
Growth Rate from 2022 to 2030 | CAGR of 17.29% |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered |
|
This study covers a detailed segmentation
of the global proton therapy market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global proton therapy market, wherein various
developments, expansions, and winning strategies practiced and implemented by
leading players have been presented in detail.
Key Players
- IBA Worldwide
- Varian medical systems, Inc
- HItachi, Ltd
- Mevion medical systems
- Sumitomo Heavy Industries, Ltd
- Optivus Proton Therapy
- Advanced Oncotherapy plc
- ProTom International
- Mitsubishi Corporation
- ProNova Solutions LLC
- Sun Nuclear Corporation
- Provision Healthcare
- Koninklijke Philips N.V
- Elekta AB
- GE Healthcare
- Best Cyclotron Systems
- Ray Search Laboratories
- Permedics
Market Segmentation
- Breast cancer
- Prostate cancer
- CNS cancer
- Head and Neck cancer
- Others
By Product
- Accelerator
- Beam transport system
- Bean delivery system
- Nozzle and image viewers
- Patient positioning system
By Type
- Rotating Proton Therapy Systems
- Non-Rotating Proton Therapy Systems
By Set-Up Systems
- Multi-Room Systems
- Compact/ Single-Room Systems
By Application Type
- Treatment Applications
- Research Applications
By End-User
- Hospitals
- Proton therapy center
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Research Methodology
The research methodology adopted by
analysts for compiling the global proton therapy market report is based on
detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary
understanding of the global proton therapy market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Proton Therapy Market
5.1. COVID-19 Landscape: Proton Therapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Proton Therapy Market, By Indication
8.1. Proton Therapy Market, by Indication, 2022-2030
8.1.1. Breast cancer
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Prostate cancer
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. CNS cancer
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Head and Neck cancer
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Proton Therapy Market, By Product
9.1. Proton Therapy Market, by Product, 2022-2030
9.1.1. Tence
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Beam transport system
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Bean delivery system
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Nozzle and image viewers
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Patient positioning system
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Proton Therapy Market, By Type
10.1. Proton Therapy Market, by Type, 2022-2030
10.1.1. Rotating Proton Therapy Systems
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Non-Rotating Proton Therapy Systems
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Proton Therapy Market, By Set-Up Systems
11.1. Proton Therapy Market, by Set-Up Systems, 2022-2030
11.1.1. Multi-Room Systems
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Compact/ Single-Room Systems
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Proton Therapy Market, By Application Type
12.1. Proton Therapy Market, by Application Type, 2022-2030
12.1.1. Treatment Applications
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Research Applications
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Proton Therapy Market, By End-User
13.1. Proton Therapy Market, by End-User, 2022-2030
13.1.1. Hospitals
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Proton therapy center
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Others
13.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Proton Therapy Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Indication (2017-2030)
14.1.2. Market Revenue and Forecast, by Product (2017-2030)
14.1.3. Market Revenue and Forecast, by Type (2017-2030)
14.1.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.1.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.1.6. Market Revenue and Forecast, by End-User (2017-2030)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Indication (2017-2030)
14.1.7.2. Market Revenue and Forecast, by Product (2017-2030)
14.1.7.3. Market Revenue and Forecast, by Type (2017-2030)
14.1.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.1.8. Market Revenue and Forecast, by Application Type (2017-2030)
14.1.8.1. Market Revenue and Forecast, by End-User (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Indication (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Product (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Type (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.1.10. Market Revenue and Forecast, by Application Type (2017-2030)
14.1.11. Market Revenue and Forecast, by End-User (2017-2030)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.6. Market Revenue and Forecast, by End-User (2017-2030)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.9. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.10. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.10.1. Market Revenue and Forecast, by End-User (2017-2030)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.12. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.13. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.14. Market Revenue and Forecast, by End-User (2017-2030)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.15.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.15.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.15.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.16. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.16.1. Market Revenue and Forecast, by End-User (2017-2030)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Indication (2017-2030)
14.2.17.2. Market Revenue and Forecast, by Product (2017-2030)
14.2.17.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.17.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.2.18. Market Revenue and Forecast, by Application Type (2017-2030)
14.2.18.1. Market Revenue and Forecast, by End-User (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.6. Market Revenue and Forecast, by End-User (2017-2030)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.7.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.7.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.8. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.9. Market Revenue and Forecast, by End-User (2017-2030)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.11. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.11.1. Market Revenue and Forecast, by End-User (2017-2030)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.12.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.12.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.12.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.12.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.12.6. Market Revenue and Forecast, by End-User (2017-2030)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Indication (2017-2030)
14.3.13.2. Market Revenue and Forecast, by Product (2017-2030)
14.3.13.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.13.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.3.13.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.3.13.6. Market Revenue and Forecast, by End-User (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.6. Market Revenue and Forecast, by End-User (2017-2030)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.7.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.7.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.8. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.9. Market Revenue and Forecast, by End-User (2017-2030)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.11. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.12. Market Revenue and Forecast, by End-User (2017-2030)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.13.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.13.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.13.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.13.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.13.6. Market Revenue and Forecast, by End-User (2017-2030)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Indication (2017-2030)
14.4.14.2. Market Revenue and Forecast, by Product (2017-2030)
14.4.14.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.14.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.4.14.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.4.14.6. Market Revenue and Forecast, by End-User (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Indication (2017-2030)
14.5.2. Market Revenue and Forecast, by Product (2017-2030)
14.5.3. Market Revenue and Forecast, by Type (2017-2030)
14.5.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.5.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.5.6. Market Revenue and Forecast, by End-User (2017-2030)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Indication (2017-2030)
14.5.7.2. Market Revenue and Forecast, by Product (2017-2030)
14.5.7.3. Market Revenue and Forecast, by Type (2017-2030)
14.5.7.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.5.8. Market Revenue and Forecast, by Application Type (2017-2030)
14.5.8.1. Market Revenue and Forecast, by End-User (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Indication (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Product (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Type (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Set-Up Systems (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Application Type (2017-2030)
14.5.9.6. Market Revenue and Forecast, by End-User (2017-2030)
Chapter 15. Company Profiles
15.1. IBA Worldwide
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Varian medical systems, Inc
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. HItachi, Ltd
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Mevion medical systems
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Sumitomo Heavy Industries, Ltd
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Optivus Proton Therapy
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Advanced Oncotherapy plc
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. ProTom International
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Mitsubishi Corporation
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. ProNova Solutions LLC
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments